The present study was specifically designed to test the possibility to inhibit the secretion of CXCL8 in thyroid cancer cells harboring specific genetic mutations and the characterization of the IFNγ signaling producing this inhibition appears by far behind the aim of our study. Here, IFNG is linked to thyroid cancer.